共 49 条
[1]
Aloia J.F., Role of calcitriol in the treatment of postmenopausal osteoporosis, Metabolism, 39, pp. 35-38, (1990)
[2]
Au W.Y.M., Inhibition by 1,25-dihydroxycholecalciferol of hormonal secretion of rat parathyroid gland in organ culture, Calcif Tissue Int, 36, pp. 384-391, (1984)
[3]
Baron R., Vignery A., Neff L., Silverglate A., Santa Maria A., Processing of undecalcified bone specimens for bone histomorphometry, Bone histomorphometry: techniques and interpretation, pp. 13-35, (1983)
[4]
Boskey A.L., Noncollagenous matrix proteins and their role in mineralization, Bone Min, 6, pp. 111-123, (1989)
[5]
Caniggia A., Nuti R., Lore F., Martini G., Turchetti V., Righi G., Long-term treatment with calcitriol in postmenopausal osteoporosis, Metabolism, 39, pp. 43-49, (1990)
[6]
Chesnut C.H., Drug therapy: calcitonin, bisphosphonates, anabolic steroids, and hPTH (1–34), Osteoporosis: etiology, diagnosis, and management, pp. 403-414, (1988)
[7]
Christiansen C., Christensen, McNair P., Hagen C., Stocklund K-E, TransbOl I., Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females, Eur J Clin Invest, 10, pp. 273-279, (1980)
[8]
Christiansen C., Christensen, ROdbro P., Hagen C., TransbOl I., Effect of 1,25-dihydroxyvitamin D<sub>3</sub> in itself or combined with hormone treatment in preventing postmenopausal osteoporosis, Eur J Clin Invest, 11, pp. 305-309, (1981)
[9]
Erben R.G., Kohn B., Rambeck W.A., Zucker H., Histomorphometric analysis of the rat proximal tibial metaphysis by “linear scanning≓, Scanning Microsc, 4, pp. 625-640, (1990)
[10]
Eriksen E.F., Colvard D.S., Berg N.J., Graham M.L., Mann K.G., Spelsberg T.C., Riggs B.L., Evidence of estrogen receptors in normal human osteoblast-like cells, Science, 241, pp. 84-86, (1988)